UTILISATION DE LIPOCALINE DES NEUTROPHILES ASSOCIEE A LA GELATINASE DANS LA FABRICATION D'UN MEDICAMENT DESTINE A LA PREVENTION OU AU TRAITEMENT DE LA POLYKYSTOSE RENALE
Disclosed is the use of neutrophil geleatinase-associated lipocalin(NGAL) in the manufacture of a medicament for prevention andtreatment of polycystic kidney diseases. By administration of NGAL,the lifespan of patients can be prolonged.